Paracetamol to minimize pain during second trimester amniocentesis

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

TCTR

Registry ID

TCTR20141127003

Enrollment

Unknown

Registered

2014-11-27

Start date

2014-10-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pregnancy GA 18&#45

Interventions

All participants were randomly assigned by computer to either the paracetamol received group or the placebo received group. The Paracetamol was taken about 30 minute before amniocentesis. Pain assess

Experimental Drug,Placebo Comparator Drug

paracetamol,Placebo

Eligibility

Sex/Gender

Female

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: pregnancy women GA 18-22 wk who came to amniocentesis singleton pregnancy no underlying disease

Exclusion criteria

Exclusion criteria: History of paracetamol allergy Multiple pregnancy Previous amniocentesis in this pregnancy Denial for the study More than one puncture of needle

Design outcomes

Primary

Measure	Time frame
pain score 30 minute VAS score	—

Secondary

Measure	Time frame
NA NA NA	—

Countries

Thailand

Contacts

Public Contactworalak Iamsumang

Lampang hospital

iampuk285@yahoo.com081-8842214

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026